In contrast BRAF-mutated NSCLC patients seems to show a higher PD-L1 expression with increased sensitivity to ICIs; however, it has not been confirmed well enough in clinic [31,37,41]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.